JR10 E-cigarette | Lighting Up the Future of Smoking Alternatives

Jan.14.2025
 JR10 E-cigarette | Lighting Up the Future of Smoking Alternatives

Making smoking healthier and more personalized, the JR10 e-cigarette is specially designed for the UK market and future European markets. With its excellent design and attractive appearance, it stands out as a leader among smoking alternatives.

 

 JR10 E-cigarette | Lighting Up the Future of Smoking Alternatives
The stylish and simple JR10 e-cigarette features a semi-transparent cartridge design and colorful lights that instantly catch the eye.

 

 

Core Highlights: Long-lasting Battery Life and Powerful Performance

 

 

The JR10 is equipped with a 650mAh rechargeable battery, supporting USB-C fast charging. It can be fully charged in less than an hour, allowing you to maintain smooth use whether at home, in the office, or on the go. Coupled with a large 2+10ML semi-transparent cartridge, it supports approximately 10,000 draws, truly achieving a perfect balance of efficiency and long-lasting battery life.

 

Imagine: No need for frequent charging and oil refills, easily meeting the needs of the whole day, making your life more convenient and efficient.

 

 JR10 E-cigarette | Lighting Up the Future of Smoking Alternatives
The semi-transparent cartridge design, makes the oil level clear at a glance, saying goodbye to dry burns and worries; the screen displays the battery level in real-time, making use smarter.

 

 

Colorful Lights Add Fun to the Experience

 

 

Every draw lights up the semi-transparent cartridge with a rainbow of colors, providing a cool visual experience. This is not just a function but also a fashion statement, suitable for modern users who pursue personalization.

 

 

Automatic Airflow Activation Mechanism, Mouth-to-Lung (MTL) Style for a More Natural Fit

 

 

The JR10 adopts an automatic airflow activation mechanism, no button operation is needed, just pick up and use, especially suitable for users who prefer the MTL (mouth-to-lung) drawing style, with a smooth and natural draw.

 

 JR10 E-cigarette | Lighting Up the Future of Smoking Alternatives
Users enjoy the JR10 effortlessly, with the MTL design closer to the traditional smoking sensation, satisfying the need for a real smoking experience.

 

 

Details are King: Thoughtful Design for Every Moment

 

  • Battery Level Screen Display: Always in control of the device status, no need to worry about the battery running out suddenly.
  • 20mg Nicotine Concentration: Precise control of nicotine cravings, meeting needs while complying with the strict regulations of the European market.
  • Semi-transparent cartridge Design: Clear oil level visibility, more worry-free use.

 

 

Born for the Future: A Dual Commitment to Safety and Environmental Sustainability

 

 

As an innovative product focused on the UK and European markets, the JR10 not only complies with local laws and health standards but also offers sustainable choices through more environmentally friendly designs.

 

The above 2+10 product is developed by Lanavape, which has not yet been officially launched on the website.

 

LANAVAPE is a well-known e-cigarette brand factory headquartered in Shenzhen, China, ranking in the top five in the Southeast Asian market and trusted by consumers. The company focuses on the research and production of disposable, Replaceable pod, and open pod-style e-cigarettes. Now, LANAVAPE is actively expanding into the European market, offering healthier and more efficient smoking alternatives to users worldwide.

China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
Huabao’s H1 2026 results show the company advancing across three connected fronts: international expansion, entry into next-generation tobacco supply chains and diversification beyond its traditional tobacco-related base. Overseas revenue rose 216.08% to CNY 96.02 million, while non-flavor businesses reached 42.2% of total revenue. Huabao also said it had entered the supply chains of leading global tobacco customers, as its nutrition, food ingredient, fragrance and personal-care businesses gained ground in Europe, Southeast Asia, Australia and New Zealand. However, adjusted net profit increased only 2.78%, and next-generation tobacco revenue was not separately disclosed, showing that the transformation is reshaping revenue and customer exposure but has yet to translate fully into underlying earnings.
Aug.28
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Philip Morris International has published its first report aligned with the Taskforce on Nature-related Financial Disclosures, bringing its electronics supply chain and the use and end-of-life stages of smoke-free devices and consumables into its nature-related assessment. PMI said its smoke-free business accounted for about 42% of total net revenues in the second quarter of 2026. The report says non-circular electronic products, particularly single-use items, can increase consumption of limited natural resources and also details an IQOS repair pilot. A 2040 circularity scenario tests assumptions including a 50% reduction in product waste-related costs, 10% raw-material savings and a 25% substitution rate for refurbished products versus new products.
Sep.23
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
HM Revenue & Customs put the UK's Vaping Products Duty and Vaping Duty Stamps Scheme into effect on October 1. All vaping liquids manufactured in or imported into the UK are now subject to duty at £2.20 per 10ml, regardless of nicotine content. The stamp regime will introduce digital functionality designed to provide traceability throughout the supply chain, with approved manufacturers, importers and warehousekeepers required to report product movements and retailers and consumers eventually able to scan stamps to verify authenticity. China exported $177 million of vape-related products to the UK in August, up 51.4% year over year, increasing the significance of the new compliance regime for China's Shenzhen-centered vape supply chain.
Regulations
Oct.04